Quantcast

Latest Lupus erythematosus Stories

2011-07-28 15:38:00

ANAHEIM, Calif., July 28, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Canaccord Genuity Growth Conference to be held August 9-11, 2011 at the InterContinental Boston in Boston, MA. Don M.

2011-07-12 10:32:00

To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/first-new-lupus-treatment-in-almost-50-years MARKHAM, ON, July 12, 2011 /PRNewswire/ - Health Canada's recent approval of BENLYSTA(TM) marks the first new treatment available in almost 50 years to the over 1:1000 Canadian men, women and children who are living with Systemic Lupus Erythematosus (SLE) an autoimmune disease with no known cause or cure.

2011-05-06 06:00:00

To view the Social Media Release, click here: http://smr.newswire.ca/en/lupus-canada/take-a-step-to-conquer-lupus MARKHAM, ON, May 6 /PRNewswire/ - In the month of May residents in communities across Canada will participate in Lupus Canada's most important public awareness and fundraising event, Walk for Lupus.

2011-05-03 16:00:00

HAYWARD, Calif., May 3, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2011.

2011-04-06 13:33:00

AWARDS AN ADDITIONAL $3.6 MILLION IN LUPUS RESEARCH, REACHING $5.6 MILLION IN 2010 NEW YORK, April 6, 2011 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) - the world's largest private funder of lupus research - today announced its most recent medical research grant awards, totaling $3.6 million, which support the ALR mission of finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus), a debilitating autoimmune disease.

2011-03-23 03:35:24

Scientists have discovered genetic defects that appear to predispose women to a common pregnancy-related medical problem called preeclampsia that can threaten the life of both baby and mother.

2011-03-11 00:00:27

The New York City-based S.L.E. Lupus Foundation and its West Coast division Lupus LA welcome the U.S.

2011-03-10 14:23:13

Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.


Word of the Day
onomatope
  • An imitative word; an onomatopoetic word.
The word 'onomatope' is a back-formation from 'onomatopoeia'.
Related